Table III.
Association between SNPs in HFE region and gastric adenocarcinoma, overall and according to localization and histological type. OR and 95% CI for log-additive model (per allele effect) estimated by unconditional logistic regression, adjusted for sex, age, center and date of blood collection
SNP | All gastric adenocarcinoma | Cardia (107 cases) | Non-cardia (181 cases) | Intestinal type (126 cases) | Diffuse type (128 cases) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cases/controls | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
rs4529296 | 363/1277 | 1.09 (0.91–1.29) | 0.35 | 1.04 (0.77–1.41) | 0.79 | 1.13 (0.90–1.43) | 0.30 | 1.22 (0.93–1.61) | 0.15 | 0.99 (0.75–1.31) | 0.97 |
rs1799945a | 323/1157 | 1.32 (1.03–1.69) | 0.031 | 1.14 (0.71–1.82) | 0.59 | 1.60 (1.16–2.21) | 0.005 | 1.82 (1.27–2.62) | 0.002 | 1.36 (0.92–1.99) | 0.13 |
rs1800562b | 365/1283 | 1.12 (0.75–1.67) | 0.59 | 0.70 (0.33–1.51) | 0.35 | 1.37 (0.81–2.32) | 0.25 | 0.95 (0.48–1.88) | 0.88 | 1.12 (0.59–2.10) | 0.74 |
rs1572982 | 365/1282 | 1.09 (0.93–1.29) | 0.29 | 1.06 (0.80–1.41) | 0.70 | 1.07 (0.86–1.34) | 0.54 | 1.40 (1.08–1.83) | 0.012 | 1.11 (0.85–1.44) | 0.45 |
rs707889 | 365/1277 | 0.96 (0.77–1.18) | 0.67 | 0.96 (0.67–1.37) | 0.81 | 0.97 (0.73–1.29) | 0.83 | 0.88 (0.62–1.24) | 0.46 | 0.85 (0.60–1.20) | 0.35 |
rs1045537 | 365/1283 | 0.96 (0.74–1.26) | 0.79 | 0.86 (0.53–1.38) | 0.51 | 0.95 (0.65–1.39) | 0.79 | 0.83 (0.52–1.32) | 0.43 | 1.24 (0.83–1.86) | 0.30 |
rs17596719 | 365/1282 | 0.95 (0.73–1.24) | 0.71 | 1.24 (0.79–1.92) | 0.35 | 0.82 (0.57–1.19) | 0.29 | 1.08 (0.73–1.61) | 0.70 | 0.80 (0.52–1.24) | 0.31 |
rs6918586 | 365/1280 | 1.11 (0.94–1.32) | 0.23 | 1.06 (0.79–1.43) | 0.68 | 1.14 (0.91–1.44) | 0.26 | 1.39 (1.06–1.82) | 0.017 | 1.17 (0.89–1.54) | 0.27 |
rs1543680 | 362/1282 | 0.93 (0.75–1.15) | 0.48 | 0.95 (0.66–1.37) | 0.80 | 0.96 (0.72–1.28) | 0.76 | 0.81 (0.57–1.15) | 0.23 | 0.82 (0.58–1.17) | 0.28 |
aH63D.
bC282Y.